PHENERGAN EXPECTORANT WITH CODEINE LIQUID
PHENERGAN EXPECTORANT WITH CODEINE LIQUID
Discontinued
DIN Number
02162180
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
columbia laboratories canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02162180
AIG Number0311735001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
CODEINE PHOSPHATEActive
Strength: 10 MG / 5 ML
Monograph: CODEINE PHOSPHATE
POTASSIUM GUAIACOL SULPHONATEActive
Strength: 40 MG / 5 ML
Monograph: POTASSIUM GUAIACOL SULPHONATE
PROMETHAZINE HYDROCHLORIDEActive
Strength: 5.65 MG / 5 ML
Monograph: PROMETHAZINE HYDROCHLORIDE